BELITE BIO INC - ADR (BLTE) Stock Income Statement
NASDAQ:BLTE - Nasdaq - US07782B1044 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 46.74M | 40.00M | 32.00M | 12.82M | 9.80M | |||
| Research and Development | N/A | N/A | 24.84M | 8.87M | 7.42M | |||
| Selling, General, and Administrative Expenses | 14.61M | 10.00M | 6.82M | 3.95M | 2.38M | |||
| Operating Income | -46.74M | -40.00M | -32.00M | -12.82M | -9.80M | |||
| Interest Income/Expense | N/A | N/A | 45.00K | 170.00K | 130.00K | |||
| Other Income/Expense | 4.64M | 4.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -42.17M | -36.00M | -32.00M | -12.65M | -9.67M | |||
| Income Tax | 0.00 | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Net Income | -42.17M | -36.00M | -32.00M | -12.65M | -9.67M | |||
| EBITDA | N/A | -39.55M | -31.60M | -12.76M | -9.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.34 | -1.17 | -1.18 | -0.62 | -0.40 | |||
| Non GAAP EPS | -1.36 | -1.18 | -1.24 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD